These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 15590326)

  • 1. Proliferation-dependent expression of nuclear uracil-DNA glycosylase is mediated in part by E2F-4.
    Muller-Weeks S; Balzer RJ; Anderson R; Caradonna S
    DNA Repair (Amst); 2005 Feb; 4(2):183-90. PubMed ID: 15590326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The nuclear isoform of the highly conserved human uracil-DNA glycosylase is an Mr 36,000 phosphoprotein.
    Muller-Weeks S; Mastran B; Caradonna S
    J Biol Chem; 1998 Aug; 273(34):21909-17. PubMed ID: 9705330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Affinity purification and comparative analysis of two distinct human uracil-DNA glycosylases.
    Caradonna S; Ladner R; Hansbury M; Kosciuk M; Lynch F; Muller S
    Exp Cell Res; 1996 Feb; 222(2):345-59. PubMed ID: 8598223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteolytic degradation of the nuclear isoform of uracil-DNA glycosylase occurs during the S phase of the cell cycle.
    Fischer JA; Muller-Weeks S; Caradonna S
    DNA Repair (Amst); 2004 May; 3(5):505-13. PubMed ID: 15084312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The nature of enzymes involved in uracil-DNA repair: isoform characteristics of proteins responsible for nuclear and mitochondrial genomic integrity.
    Caradonna S; Muller-Weeks S
    Curr Protein Pept Sci; 2001 Dec; 2(4):335-47. PubMed ID: 12369930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E2F sites in the Op18 promoter are required for high level of expression in the human prostate carcinoma cell line PC-3-M.
    Polzin RG; Benlhabib H; Trepel J; Herrera JE
    Gene; 2004 Oct; 341():209-18. PubMed ID: 15474303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of expression of nuclear and mitochondrial forms of human uracil-DNA glycosylase.
    Haug T; Skorpen F; Aas PA; Malm V; Skjelbred C; Krokan HE
    Nucleic Acids Res; 1998 Mar; 26(6):1449-57. PubMed ID: 9490791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct recruitment of E2F family members to specific E2F-binding sites mediates activation and repression of the E2F1 promoter.
    Araki K; Nakajima Y; Eto K; Ikeda MA
    Oncogene; 2003 Oct; 22(48):7632-41. PubMed ID: 14576826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
    Zhou D; Masri S; Ye JJ; Chen S
    Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of transcription of the human MRP7 gene. Characteristics of the basal promoter and identification of tumor-derived transcripts encoding additional 5' end heterogeneity.
    Dabrowska M; Sirotnak FM
    Gene; 2004 Oct; 341():129-39. PubMed ID: 15474296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of transcription factor AP-2 stimulates the PA promoter of the human uracil-DNA glycosylase (UNG) gene through a mechanism involving derepression.
    Aas PA; Peña-Diaz J; Liabakk NB; Krokan HE; Skorpen F
    DNA Repair (Amst); 2009 Jul; 8(7):822-33. PubMed ID: 19411194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different organization of base excision repair of uracil in DNA in nuclei and mitochondria and selective upregulation of mitochondrial uracil-DNA glycosylase after oxidative stress.
    Akbari M; Otterlei M; Peña-Diaz J; Krokan HE
    Neuroscience; 2007 Apr; 145(4):1201-12. PubMed ID: 17101234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in DNA binding properties between E2F1 and E2F4 specify repression of the Mcl-1 promoter.
    Croxton R; Ma Y; Cress WD
    Oncogene; 2002 Feb; 21(10):1563-70. PubMed ID: 11896585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell cycle-dependent regulation of the human aurora B promoter.
    Kimura M; Uchida C; Takano Y; Kitagawa M; Okano Y
    Biochem Biophys Res Commun; 2004 Apr; 316(3):930-6. PubMed ID: 15033491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The transcription factor, NFI/CTF plays a positive regulatory role in expression of the hSMUG1 gene.
    Elateri I; Muller-Weeks S; Caradonna S
    DNA Repair (Amst); 2003 Dec; 2(12):1371-85. PubMed ID: 14642566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and initial characterization of the BRCA2 promoter.
    Davis PL; Miron A; Andersen LM; Iglehart JD; Marks JR
    Oncogene; 1999 Oct; 18(44):6000-12. PubMed ID: 10557089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell cycle-dependent regulation of the bi-directional overlapping promoter of human BRCA2/ZAR2 genes in breast cancer cells.
    Misra S; Sharma S; Agarwal A; Khedkar SV; Tripathi MK; Mittal MK; Chaudhuri G
    Mol Cancer; 2010 Mar; 9():50. PubMed ID: 20202217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
    Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
    Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E2F binding is required but not sufficient for repression of B-myb transcription in quiescent fibroblasts.
    Bennett JD; Farlie PG; Watson RJ
    Oncogene; 1996 Sep; 13(5):1073-82. PubMed ID: 8806697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of dihydrofolate reductase gene expression and E2F components in human diploid fibroblasts during growth and senescence.
    Good L; Dimri GP; Campisi J; Chen KY
    J Cell Physiol; 1996 Sep; 168(3):580-8. PubMed ID: 8816912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.